Why Invest in Amphasys?

A Revolution in Cell Biology

We are at the beginning of a revolution in cell biology, triggered by the new megatrends “cellular agriculture”, “precision fermentation” and “regenerative medicine”.[1] Cells are the smallest units of life, powerful molecular factories. Just think about healthy food, CO2-neutral biofuels or cell therapy.

Many companies are pushing these developments. But they are literally blind because they cannot assess the quality of cells where and how fast they need it. This leads to losses in production and a cost savings potential of about 20% and more.

There is no other solution than ours which provides such detailed information and is portable and fast with an excellent value for money! We empower seed companies, breweries, biofuel producers, milk processing factories, pharmaceutical and medical companies, to take faster, better and data-driven decisions to save billions of Euros. More than 100 paying customers like BASF, Bayer, Syngenta, Doppelleu Brewery and many universities are proof that it works.

With patents that protect our main markets, worth € 1.8 Bn, we are in an excellent position for further growth based on a “printer/cartridge”-like business model.

To boost international commercialization and pre-finance production we are looking for strategic investors.

For more information, please contact our CEO, Dr. Marcel Ottiger.

One Solution...

Proven third-generation “printer/cartridge-like” technology.


  • Label-free
  • Portable
  • Fast and automated
  • Multi-parametric
  • OEM-ready

...Many Applications

Seed Production

10% higher yield, value of € 5 Bn p.a.

20% faster beer and bio-fuels production, higher yield for pharma

Immediate on-site result = 1 day faster than today

Unique for specific needs in regenerative medicine, toxicology, bacterial infections

Current Customers

[1] See “Rethinking Food and Agriculture 2020-2030”, A RethinkX Sector Disruption Report